265 related articles for article (PubMed ID: 2540496)
1. Biochemical basis for the interactions of type I and type II topoisomerases with DNA.
Osheroff N
Pharmacol Ther; 1989; 41(1-2):223-41. PubMed ID: 2540496
[TBL] [Abstract][Full Text] [Related]
2. Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.
Liu LF; Liu CC; Alberts BM
Cell; 1980 Mar; 19(3):697-707. PubMed ID: 6244895
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
4. Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases.
Jian JY; Osheroff N
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446377
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage.
Riou JF; Gabillot M; Philippe M; Schrevel J; Riou G
Biochemistry; 1986 Apr; 25(7):1471-9. PubMed ID: 3011062
[TBL] [Abstract][Full Text] [Related]
6. What's on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases.
Vidmar V; Vayssières M; Lamour V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835394
[TBL] [Abstract][Full Text] [Related]
7. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
[TBL] [Abstract][Full Text] [Related]
8. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.
Boege F
Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461
[TBL] [Abstract][Full Text] [Related]
9. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents.
Pogorelčnik B; Perdih A; Solmajer T
Curr Med Chem; 2013; 20(5):694-709. PubMed ID: 23210851
[TBL] [Abstract][Full Text] [Related]
12. The response of eukaryotic topoisomerases to DNA damage.
Kingma PS; Osheroff N
Biochim Biophys Acta; 1998 Oct; 1400(1-3):223-32. PubMed ID: 9748592
[TBL] [Abstract][Full Text] [Related]
13. New mechanistic and functional insights into DNA topoisomerases.
Chen SH; Chan NL; Hsieh TS
Annu Rev Biochem; 2013; 82():139-70. PubMed ID: 23495937
[TBL] [Abstract][Full Text] [Related]
14. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
15. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.
Robinson MJ; Osheroff N
Biochemistry; 1991 Feb; 30(7):1807-13. PubMed ID: 1847075
[TBL] [Abstract][Full Text] [Related]
16. GTP induces knotting, catenation, and relaxation of DNA by stoichiometric amounts of DNA topoisomerase II from Bombyx mori and HeLa cells.
Hirose S; Tabuchi H; Yoshinaga K
J Biol Chem; 1988 Mar; 263(8):3805-10. PubMed ID: 2831204
[TBL] [Abstract][Full Text] [Related]
17. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
Li G; Tolstonog GV; Sabasch M; Traub P
DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
[TBL] [Abstract][Full Text] [Related]
18. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.
Schmidt BH; Burgin AB; Deweese JE; Osheroff N; Berger JM
Nature; 2010 Jun; 465(7298):641-4. PubMed ID: 20485342
[TBL] [Abstract][Full Text] [Related]
19. Energy coupling in type II topoisomerases: why do they hydrolyze ATP?
Bates AD; Maxwell A
Biochemistry; 2007 Jul; 46(27):7929-41. PubMed ID: 17580973
[TBL] [Abstract][Full Text] [Related]
20. The use of divalent metal ions by type II topoisomerases.
Deweese JE; Osheroff N
Metallomics; 2010 Jul; 2(7):450-9. PubMed ID: 20703329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
